Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Change in Cash (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Change in Cash for 2 consecutive years, with -$1.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Cash rose 86.07% to -$1.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.1 million, a N/A change, with the full-year FY2024 number at $9.8 million, up 105.78% from a year prior.
  • Change in Cash was -$1.8 million for Q3 2025 at Pyxis Oncology, up from -$2.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $18.3 million in Q1 2024 to a low of -$13.0 million in Q3 2024.